Last reviewed · How we verify

NCT04120792

The Aerobic and Cognitive Training System

Completed NA Last updated 9 October 2019
What this trial tests

NA trial testing Simultaneous exercise and cognitive training in Healthy Aging in 74 participants. Completed in 20 November 2017.

Timeline
1 May 2015
Primary endpoint
20 November 2017
20 November 2017

Quick facts

Lead sponsorUniversity of Arizona
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment74
Start date1 May 2015
Primary completion20 November 2017
Estimated completion20 November 2017

Drugs / interventions tested

Conditions studied

Sponsor

University of Arizona

Who can join

Adults 60 to 74, any sex, with Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will determine the effects of simultaneous exercise and cognitive training on cognitive function in healthy older adults. Specifically, this study will compare the use of a tablet-based cognitive training system while exercising with exercise alone, cognitive training alone, and a neutral control condition on cognition.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of simultaneous cognitive and aerobic exercise training on dual-task walking performance in healthy older adults: results from a pilot randomized controlled trial.
    Raichlen DA, Bharadwaj PK, Nguyen LA, Franchetti MK, et al · · 2020 · cited 42× · PMID 32122325 · DOI 10.1186/s12877-020-1484-5

Verify or expand the search:

Other recruiting trials for Healthy Aging

Currently open trials in the same condition.

Other University of Arizona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04120792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing